Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA Evaluates Peptides for Section 503A Compounding List Lance Liberti, MBA, BCPA posted on the topic LinkedIn peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law